Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "Hanmi Pharmaceutical"
Home
“Half the Price of Mounjaro”: South Korea’s First Homegrown Obesity Drug Epe Enters the Market
The first domestically developed obesity medication is entering South Korea’s weight-loss market, long dominated by foreign pharmaceuticals such as...
11/09/2026, 01:01 ET
Hanmi’s ‘Epe’ Wins MFDS Approval, Becoming South Korea’s First Homegrown GLP-1 Obesity Drug
A domestically developed therapy has entered South Korea’s obesity treatment market, long dominated by imported products such as Wegovy and Mounjaro.
10/16/2026, 22:37 ET
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro
Efpeglenatide, a drug candidate whose development rights were once returned by a global pharmaceutical giant, is...
10/16/2026, 04:57 ET
Hanmi Pharmaceutical Unveils Next-Gen Cancer Tech Targeting Tumor Microenvironment
Hanmi Pharmaceutical has unveiled a next-generation cancer technology designed to deliver drugs to the tumor...
10/12/2026, 02:39 ET
Early Flu Outbreak Shifts Demand to Ibuprofen-Based Cold Remedies as Hanmi Leads Market
With wide daily temperature fluctuations causing seasonal influenza to spread nearly a month earlier than usual in...
09/25/2026, 10:06 ET
Hanmi Group Unveils ‘Anne’ Character to Unify Popular OTC Brand Lineup
Sore-throat spray "Mok-Anne" and artificial tear formula "Nun-Anne"—two familiar over-the-counter products in South...
09/21/2026, 22:29 ET
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon
During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
09/12/2026, 04:20 ET
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour
Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
09/03/2026, 05:34 ET
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
08/27/2026, 23:49 ET
Hanmi Pharmaceutical’s Paltan Smart Plant Cuts Drug Stockouts 57% Following Reorganization
Stockout cases have dropped sharply at Hanmi Pharmaceutical’s primary manufacturing base for synthetic drugs.
08/20/2026, 01:54 ET
1
2
3
Next